Efficacy of moclobemide in burning mouth syndrome: A nonrandomized, open-label study

Journal of Orofacial Pain

Volumn 22, Issue 2, 2008, Pages 146-152

  Pekiner, Filiz Namdar ^a   Gumru, Birsay ^a   Ozbayrak, Semih ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Anxiety; Burning mouth syndrome; Depression; Moclobemide; Pain measurement; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; MOCLOBEMIDE;

ANALYSIS OF VARIANCE; ANXIETY; ARTICLE; BURNING MOUTH SYNDROME; CASE CONTROL STUDY; CLINICAL TRIAL; DEPRESSION; FEMALE; HUMAN; MALE; MENSTRUATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; ANXIETY; BURNING MOUTH SYNDROME; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MENSTRUATION; MOCLOBEMIDE;

EID: 44849113595     PISSN: 10646655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Suarez P, Clark GT. Burning mouth syndrome: An update on diagnosis and treatment methods. J Calif Dent Assoc 2006;34:611-622.
2. Al Quran FA. Psychological profile in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:339-344.
3. Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome. Am Fam Physician 2002;65:615-620.
4. Zakrzewska JM. The burning mouth syndrome remains an enigma. Pain 1995;62:253-257.
5. Lamey PJ, Freeman R, Eddie SA, Pankhurst C, Rees T. Vulnerability and presenting symptoms in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:48-54.
6. Pekiner FN, Ozbayrak S, Canakci E. Burning mouth syndrome in patients wearing prosthesis: Evaluation of type I and type II. The Pain Clinic 2005;17:269-273.
7. Zegarelli DJ. Burning mouth: An analysis of 57 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1984;58:34-38.
8. Lamb AB, Lamey PJ, Reeve PE. Burning mouth syndrome: Psychological aspects. Br Dent J 1988;165:256-260.
9. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: Overview and patient management. Crit Rev Oral Biol Med 2003;14:275-291.
10. Browning S, Hislop S, Scully C, Shirlaw P. The association between burning mouth syndrome and psychosocial disorders. Oral Surg Oral Med Oral Pathol 1987;64:171-174.
11. Hampf G, Vikkula J, Ylipaavalniemi P, Aalberg V. Psychiatric disorders in orofacial dysaesthesia. Int J Maxillofac Surg 1987;16:402-407.
12. van der Ploeg HM, van der Wal N, Eijkman MA, van der Waal I. Psychological aspects of patients with burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1987;63:664-668.
13. Grushka M, Sessle BJ, Miller R. Pain and personality profiles in burning mouth syndrome. Pain 1987;28:155-167.
14. Bergdahl J, Anneroth G, Perris H. Personality characteristics of patients with resistant burning mouth syndrome. Acta Odontol Scand 1995;53:7-11.
15. Jerlang BB. Burning mouth syndrome (BMS) and the concept of alexithymia - A preliminary study. J Oral Pathol Med 1997;26:249-253.
16. Rojo L, Silvestre FJ, Bagan JV, De Vicente T. Psychiatric morbidity in burning mouth syndrome. Psychiatric interview versus depression and anxiety scales. Oral Surg Oral Med Oral Pathol 1993;75:308-311.
17. Forabosco A , Criscuolo M, Coukos G, et al. Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol 1992;73:570-574.
18. Forssell H, Tasmuth T, Tenovuo O, Hampf G, Kalso E. Venlafaxine in the treatment of atypical facial pain: A randomized controlled trial. J Orofac Pain 2004;18:131-137.
19. Grushka M, Sessle BJ, Howley TP. Psychophysical evidence of taste dysfunction in burning mouth syndrome. Chem Senses 1986;11:485-498.
20. Grushka M, Sessle BJ, Howley TP. Psychophysical assessment of tactile, pain, and thermal sensory functions in burning mouth syndrome. Pain 1987;28:169-184.
21. Svensson P, Kaaber S. General health factors and denture function in patients with burning mouth syndrome and matched control subjects. J Oral Rehabil 1995;22:887-895.
22. Maina G, Vitalucci A, Gandolfo S, Bogetto F. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: A single-blind study. J Clin Psychiatry 2002;63:38-43.
23. Zilli C, Brooke RI, Lau CL, Merskey H. Screening for psychiatric illness in patients with oral dysaesthesia by means of the General Health Questionnaire-twenty-eight item version (GHQ-28) and Irritability, Depression and Anxiety Scale (IDA). Oral Surg Oral Med Oral Pathol 1989;67:384-389.
24. Lamey PJ, Lamb AB, Hughes A, Milligan KA, Forsyth A. Type 3 burning mouth syndrome: Psychological and allergic aspects. J Oral Pathol Med 1994;23:216-219.
25. Eli I, Kleinhauz M, Baht R, Littner M. Antecedents of burning mouth syndrome (glossodynia) - Recent life events vs. psychopathologic aspects. J Dent Res 1994;73:567-572.
26. Lamey PJ, Lamb AB. Prospective study of aetiological factors in burning mouth syndrome. Br Med J 1988;296:1243-1246.
27. Zung WWK. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63-70.
28. Bonnet U. Moclobemide: Therapeutic use and clinical studies. CNS Drug Rev 2003;9:97-140.
29. Kendrick DB, Strout TD. The minimum clinically significant difference in patient-assigned numeric scores for pain. Am J Emerg Med 2005;23:828-832.
30. Cepeda MS, Africano JM, Polo R, Alcala R, Carr DB. What decline in pain intensity is meaningful to patients with acute pain? Pain 2003;105:151-157.
31. ten Klooster PM, Drossaers-Bakker KW, Taal E, van de Laar MA. Patient-perceived satisfactory improvement (PPSI): Interpreting meaningful change in pain from the patient's perspective. Pain 2006;121:151-157.
32. Lamey PJ, Lamb AB. The usefulness of the HAD scale in assessing anxiety and depression in patients with burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1989;67:390-392.
33. Pedersen AML, Smidt D, Nauntofte B, Christiani CJ, Jerlang BB. Burning mouth syndrome: Etiopathogenic mechanisms, symptomatology, diagnosis and therapeutic approaches. Oral Biosci Med 2004;1:3-19.
34. Wardrop RW, Hailes J, Burger H, Reade PC. Oral discomfort at menopause. Oral Surg Oral Med Oral Pathol 1989;67:535-540.
35. Grushka M. Clinical features of burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1987;63:30-36.
36. Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome: A systematic review. J Orofac Pain 2003;17:293-300.
37. Pinto A, Sollecito TP, DeRossi SS. Burning mouth syndrome. A retrospective analysis of clinical characteristics and treatment outcomes. N Y State Dent J 2003;69:18-24.
38. Feinmann C, Harris M, Cawley R. Psychogenic facial pain: Presentation and treatment. Br Med J 1984;288:436-438.
39. Woda A, Navez ML, Picard P, Gremeau C, Pichard-Leandri E. A possible therapeutic solution for stomatodynia (burning mouth syndrome). J Orofac Pain 1998;12:272-278.
40. Petruzzi M, Lauritano D, De Benedittis M, Baldoni M, Serpico R. Systemic capsaicin for burning mouth syndrome: Short-term results of a pilot study. J Oral Pathol Med 2004;33:111-114.
41. Lotufo-Neto F, Trivedi M, Thase ME. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression. Neuropsychopharmacology 1999;20:226-247.
42. Dingemanse J, Kneer J, Fotteler B, Groen H, Peeters P, Jonkman JH. Switch in treatment from tricyclic antidepressants to moclobemide: A new generation monoamine oxidase inhibitor. J Clin Psychopharmacol 1995;15:41-48.
43. Silverstone T. Moclobemide-Placebo controlled trials. Int Clin Psychopharmacol 1993;7:133-136.
44. Feine JS, Lavigne GJ, Dao TT, Morin C, Lund JP. Memories of chronic pain and perceptions of relief. Pain 1998;77:137-141.